HARMONIA trial will assess multi-system efficacy, safety and tolerability of z-basivarsen in DM1 - - 48-week trial will enroll approximately 150 individuals, and first sites are now open for ...
RAP-219’s lead program demonstrated robust and consistent activity in patients with focal onset seizures (FOS) in Phase 2a trial; initiation of Phase 3 program expected in the second quarter of 2026 ...
LGBTQ Nation on MSN
Study shows testosterone therapy does not increase anger, irritability, or aggression in trans youth
The data debunks a claim made by anti-trans activists related to mass shootings.
The University of Chicago Medicine launched a new mobile dental clinic that brings no-cost oral healthcare directly to community members.
By sticking to daylight savings time, British Columbians will strike a blow for common sense and possibly save some lives ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する